세계의 동물 의료 시장 : 제품 유형별, 동물 유형별, 최종 사용자별 - 예측(2025-2030년)

The Animal Health Market was valued at USD 83.85 billion in 2023, expected to reach USD 90.62 billion in 2024, and is projected to grow at a CAGR of 8.38%, to USD 147.38 billion by 2030.

The scope of the animal health market encompasses industries and sectors involved in the prevention, diagnosis, and treatment of diseases affecting animals, ranging from livestock and poultry to companion animals. This market plays a crucial role in ensuring food safety, public health, and animal welfare. The necessity of this market arises from the growing prevalence of zoonotic diseases, increasing livestock production to meet rising protein demand, and the human-animal bond's enhancement fueling the pet industry. Applications include pharmaceuticals, vaccines, diagnostic tools, and feed additives, each critical in maintaining animal health and productivity. The end-use scope extends beyond farmers and pet owners to include veterinary hospitals, research institutions, and pharmaceutical companies.

Market insights reveal several key factors influencing growth: advancing technology in diagnostics and therapeutics, a heightened focus on sustainable livestock practices, and robust investment in R&D for novel treatments. Opportunities arise particularly in developing regions with expanding livestock sectors and underserved pet healthcare markets. For stakeholders, prioritizing technological integration, like digital health monitoring systems, and expanding to burgeoning markets could leverage growth. However, the market faces challenges such as strict regulatory environments, the high cost of avant-garde technologies, and potential antibiotic resistance issues, which may impede progress.

Areas ripe for innovation include developing alternative treatments to antibiotics, enhancing vaccine production for broader disease coverage, and improving genetic research to engineer disease-resistant animals. Additionally, the increased application of AI and IoT in animal health monitoring offers pathways to revolutionize the industry by enabling precise health tracking and data-driven treatment plans. The nature of the market is dynamic and competitive, characterized by frequent mergers and acquisitions aiming to consolidate expertise and broaden portfolio offerings. Current limitations emphasize the need for harmonized regulatory frameworks and investment in education to overcome visibility and accessibility barriers. By addressing these challenges, the market can continue its growth trajectory, while fostering innovations that promise both economic and social dividends.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Animal Health Market

The Animal Health Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing incidences of zoonotic and food-borne diseases
  • Government initiative and support for the adoption of animal welfare
  • Growing rate of pet adoption with increased intervention toward animal health
• Market Restraints
  • Limited availability and acceptance and dearth of veterinarians
• Market Opportunities
  • Accelerating research and development activities for launching new and innovative products
  • Rising availability and adoption of pet insurance
• Market Challenges
  • Restrictions imposed by regulatory authorities on the use of antibiotics

Porter's Five Forces: A Strategic Tool for Navigating the Animal Health Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Animal Health Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Animal Health Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Animal Health Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Animal Health Market

A detailed market share analysis in the Animal Health Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Animal Health Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Animal Health Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Animal Health Market

A strategic analysis of the Animal Health Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Animal Health Market, highlighting leading vendors and their innovative profiles. These include BioChek BV, bioMerieux SA, Boehringer Ingelheim GmbH, Cadila Healthcare Limited, Ceva Animal Health LLC, Covetrus, Inc., Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Heska Corporation, HIPRA, S.A., IDEXX Laboratories, Inc., INDICAL Bioscience GmbH, Merck & Co., Inc., Norbrook Holdings Limited, Phibro Animal Health Corporation, Randox Laboratories Ltd., Thermo Fisher Scientific, Inc, Vetoquinol Group, Virbac S.A, and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Animal Health Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Biologics, Diagnostics, Equipment & Disposables, Medicinal Feed Additives, and Pharmaceuticals. The Biologics is further studied across Vaccine. The Vaccine is further studied across Inactivated (Killed) and Modified/ Attenuated Live. The Diagnostics is further studied across Consumables, Reagents, & Kits and Instruments & Devices. The Equipment & Disposables is further studied across Anesthesia Equipment, Critical Care Consumables, Fluid Management Equipment, Patient Monitoring Equipment, Rescue & Resuscitation Equipment, Research Equipment, and Temperature Management Equipment. The Pharmaceuticals is further studied across Analgesics, Anti-infectives, Anti-inflammatory, and Parasiticides.
• Based on Animal Type, market is studied across Companion Animal and Farm Animal. The Companion Animal is further studied across Cats, Dogs, and Horses. The Farm Animal is further studied across Cattle, Poultry, Sheep & Goats, and Swine.
• Based on End User, market is studied across Farmers & Ranchers, Pet Owners, and Veterinarians.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing incidences of zoonotic and food-borne diseases
    • 5.1.1.2. Government initiative and support for the adoption of animal welfare
    • 5.1.1.3. Growing rate of pet adoption with increased intervention toward animal health
  • 5.1.2. Restraints
    • 5.1.2.1. Limited availability and acceptance and dearth of veterinarians
  • 5.1.3. Opportunities
    • 5.1.3.1. Accelerating research and development activities for launching new and innovative products
    • 5.1.3.2. Rising availability and adoption of pet insurance
  • 5.1.4. Challenges
    • 5.1.4.1. Restrictions imposed by regulatory authorities on the use of antibiotics
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Growing usage of medicinal feed additives to promote health and prevent diseases
  • 5.2.2. End User: Growing adoption of animal health products by veterinarians for the maintenance of animal health and welfare across different settings
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Animal Health Market, by Product

• 6.1. Introduction
• 6.2. Biologics
  • 6.2.1. Vaccine
    • 6.2.1.1. Inactivated (Killed)
    • 6.2.1.2. Modified/ Attenuated Live
• 6.3. Diagnostics
  • 6.3.1. Consumables, Reagents, & Kits
  • 6.3.2. Instruments & Devices
• 6.4. Equipment & Disposables
  • 6.4.1. Anesthesia Equipment
  • 6.4.2. Critical Care Consumables
  • 6.4.3. Fluid Management Equipment
  • 6.4.4. Patient Monitoring Equipment
  • 6.4.5. Rescue & Resuscitation Equipment
  • 6.4.6. Research Equipment
  • 6.4.7. Temperature Management Equipment
• 6.5. Medicinal Feed Additives
• 6.6. Pharmaceuticals
  • 6.6.1. Analgesics
  • 6.6.2. Anti-infectives
  • 6.6.3. Anti-inflammatory
  • 6.6.4. Parasiticides

7. Animal Health Market, by Animal Type

• 7.1. Introduction
• 7.2. Companion Animal
  • 7.2.1. Cats
  • 7.2.2. Dogs
  • 7.2.3. Horses
• 7.3. Farm Animal
  • 7.3.1. Cattle
  • 7.3.2. Poultry
  • 7.3.3. Sheep & Goats
  • 7.3.4. Swine

8. Animal Health Market, by End User

• 8.1. Introduction
• 8.2. Farmers & Ranchers
• 8.3. Pet Owners
• 8.4. Veterinarians

9. Americas Animal Health Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Animal Health Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Animal Health Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Phibro Animal Health's USD 350 Million Acquisition of Zoetis' Product Portfolio to Boost Global Reach and Manufacturing Capacity
  • 12.3.2. Merck & Co., Inc. Strengthens Aquaculture Presence with Elanco Animal Health Acquisition
  • 12.3.3. MSD Animal Health Introduces Falcon Biomass to Revolutionize Fish Farming Efficiency and Welfare
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. BioChek BV
• 2. bioMerieux SA
• 3. Boehringer Ingelheim GmbH
• 4. Cadila Healthcare Limited
• 5. Ceva Animal Health LLC
• 6. Covetrus, Inc.
• 7. Dechra Pharmaceuticals PLC
• 8. Elanco Animal Health Incorporated
• 9. Heska Corporation
• 10. HIPRA, S.A.
• 11. IDEXX Laboratories, Inc.
• 12. INDICAL Bioscience GmbH
• 13. Merck & Co., Inc.
• 14. Norbrook Holdings Limited
• 15. Phibro Animal Health Corporation
• 16. Randox Laboratories Ltd.
• 17. Thermo Fisher Scientific, Inc
• 18. Vetoquinol Group
• 19. Virbac S.A
• 20. Zoetis Inc.